Lynette P. Steele

1.4k total citations
19 papers, 1.0k citations indexed

About

Lynette P. Steele is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Lynette P. Steele has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Genetics. Recurrent topics in Lynette P. Steele's work include Virus-based gene therapy research (9 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (5 papers). Lynette P. Steele is often cited by papers focused on Virus-based gene therapy research (9 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (5 papers). Lynette P. Steele collaborates with scholars based in United Kingdom, United States and Canada. Lynette P. Steele's co-authors include Peter J. Selby, Alan Melcher, Fiona Errington‐Mais, Richard G. Vile, Kevin J. Harrington, Hardev Pandha, Robin Prestwich, Elizabeth J. Ilett, Matt Coffey and Nikolaos T. Georgopoulos and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Lynette P. Steele

19 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynette P. Steele United Kingdom 15 613 506 362 337 229 19 1.0k
Johanna K. Kaufmann Germany 13 497 0.8× 551 1.1× 451 1.2× 325 1.0× 135 0.6× 26 1.0k
Joan Kyula United Kingdom 21 443 0.7× 576 1.1× 460 1.3× 161 0.5× 130 0.6× 33 1.0k
Hédi Haddada France 24 577 0.9× 522 1.0× 725 2.0× 293 0.9× 84 0.4× 50 1.2k
Assia L. Angelova Germany 14 582 0.9× 440 0.9× 250 0.7× 115 0.3× 224 1.0× 34 733
Zeng B. Zhu United States 24 776 1.3× 552 1.1× 823 2.3× 387 1.1× 52 0.2× 45 1.4k
Heung Chong United Kingdom 18 758 1.2× 537 1.1× 874 2.4× 498 1.5× 66 0.3× 36 1.5k
Sari Pesonen Finland 16 734 1.2× 629 1.2× 448 1.2× 213 0.6× 108 0.5× 24 947
Mari Hirvinen Finland 13 651 1.1× 550 1.1× 361 1.0× 236 0.7× 113 0.5× 19 878
Hongjie Wang United States 23 904 1.5× 444 0.9× 903 2.5× 177 0.5× 178 0.8× 49 1.4k
Marie‐Claude Bourgeois‐Daigneault Canada 18 542 0.9× 1.0k 2.1× 561 1.5× 1.0k 3.0× 104 0.5× 37 1.9k

Countries citing papers authored by Lynette P. Steele

Since Specialization
Citations

This map shows the geographic impact of Lynette P. Steele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynette P. Steele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynette P. Steele more than expected).

Fields of papers citing papers by Lynette P. Steele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynette P. Steele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynette P. Steele. The network helps show where Lynette P. Steele may publish in the future.

Co-authorship network of co-authors of Lynette P. Steele

This figure shows the co-authorship network connecting the top 25 collaborators of Lynette P. Steele. A scholar is included among the top collaborators of Lynette P. Steele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynette P. Steele. Lynette P. Steele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Steele, Lynette P., et al.. (2021). Non-redundant activity of GSK-3α and GSK-3β in T cell-mediated tumor rejection. iScience. 24(6). 102555–102555. 9 indexed citations
2.
Hope, Helen Carrasco, Rebecca J. Brownlie, Christopher M. Fife, et al.. (2021). Coordination of asparagine uptake and asparagine synthetase expression modulates CD8+ T cell activation. JCI Insight. 6(9). 32 indexed citations
3.
Brüning‐Richardson, Anke, Tim Brend, Hitesh J. Sanganee, et al.. (2021). GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers. 13(23). 5939–5939. 4 indexed citations
4.
Steele, Lynette P., Aat A. Mulder, Diana J.M. van den Wollenberg, et al.. (2018). Antibody-Neutralized Reovirus Is Effective in Oncolytic Virotherapy. Cancer Immunology Research. 6(10). 1161–1173. 53 indexed citations
5.
Steele, Lynette P., Anke Brüning‐Richardson, Angus Davison, et al.. (2017). P11.15 Selective inhibition of BCL-XL increases sensitivity of pediatric tumour models to the anti-mitotic agent MLN8237. Neuro-Oncology. 19(suppl_3). iii94–iii94. 1 indexed citations
6.
Steele, Lynette P., Anke Brüning‐Richardson, Adam Davison, et al.. (2017). Selective BCL-XL inhibition promotes apoptosis in combination with MLN8237 in medulloblastoma and pediatric glioblastoma cells. Neuro-Oncology. 20(2). 203–214. 25 indexed citations
7.
Parrish, Christopher, Gina B. Scott, G Migneco, et al.. (2015). Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia. Leukemia. 29(9). 1799–1810. 32 indexed citations
8.
Steele, Lynette P., et al.. (2013). ABT-263 Enhances Sensitivity to Metformin and 2-Deoxyglucose in Pediatric Glioma by Promoting Apoptotic Cell Death. PLoS ONE. 8(5). e64051–e64051. 26 indexed citations
9.
Steele, Lynette P., Fiona Errington‐Mais, Robin Prestwich, et al.. (2011). Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming. Molecular Cancer. 10(1). 20–20. 61 indexed citations
10.
Donnelly, Oliver, Fiona Errington‐Mais, Lynette P. Steele, et al.. (2011). Measles virus causes immunogenic cell death in human melanoma. Gene Therapy. 20(1). 7–15. 155 indexed citations
11.
Kelly, John J., Michael Blough, Jennifer A. Chan, et al.. (2010). Oligodendroglioma cell lines containing t(1;19)(q10;p10). Neuro-Oncology. 12(7). 745–755. 58 indexed citations
12.
Harvey, Tracey J., Lynette P. Steele, Nicola Ingram, et al.. (2010). Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor. Gene Therapy. 17(8). 1000–1010. 14 indexed citations
13.
Prestwich, Robin, Fiona Errington‐Mais, Lynette P. Steele, et al.. (2009). Reciprocal Human Dendritic Cell–Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus. The Journal of Immunology. 183(7). 4312–4321. 66 indexed citations
14.
Prestwich, Robin, Elizabeth J. Ilett, Fiona Errington‐Mais, et al.. (2009). Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication. Clinical Cancer Research. 15(13). 4374–4381. 141 indexed citations
15.
Errington‐Mais, Fiona, Charles L. White, Katie Twigger, et al.. (2008). Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma. Gene Therapy. 15(18). 1257–1270. 86 indexed citations
16.
Errington‐Mais, Fiona, Lynette P. Steele, Robin Prestwich, et al.. (2008). Reovirus Activates Human Dendritic Cells to Promote Innate Antitumor Immunity. The Journal of Immunology. 180(9). 6018–6026. 150 indexed citations
17.
Errington‐Mais, Fiona, Lynette P. Steele, Alison Merrick, et al.. (2008). OK432-Activated Human Dendritic Cells Kill Tumor Cells via CD40/CD40 Ligand Interactions. The Journal of Immunology. 181(5). 3108–3115. 26 indexed citations
18.
Steele, Lynette P., Nikolaos T. Georgopoulos, Jennifer Southgate, Peter J. Selby, & L K Trejdosiewicz. (2006). Differential susceptibility to TRAIL of normal versus malignant human urothelial cells. Cell Death and Differentiation. 13(9). 1564–1576. 31 indexed citations
19.
Georgopoulos, Nikolaos T., et al.. (2006). A novel mechanism of CD40-induced apoptosis of carcinoma cells involving TRAF3 and JNK/AP-1 activation. Cell Death and Differentiation. 13(10). 1789–1801. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johanna K. Kaufmann Breakdown of academic impact, for papers by Joan Kyula Breakdown of academic impact, for papers by Hédi Haddada Breakdown of academic impact, for papers by Assia L. Angelova Breakdown of academic impact, for papers by Zeng B. Zhu Breakdown of academic impact, for papers by Heung Chong Breakdown of academic impact, for papers by Sari Pesonen Breakdown of academic impact, for papers by Mari Hirvinen Breakdown of academic impact, for papers by Hongjie Wang Breakdown of academic impact, for papers by Marie‐Claude Bourgeois‐Daigneault
Rankless by CCL
2026